A push by Japan’s biggest drugmaker to globalise has come under attack by more than 100 former executives and shareholders, casting a cloud over broader efforts by the country’s top companies to internationalise.
In a letter to Takeda Pharmaceutical, 110 former executives and individual investors questioned the company’s appointment of non-Japanese to several senior positions.
Help employers find you! Check out all the jobs and post your resume.
